Figure 5 | Scientific Reports

Figure 5

From: Empagliflozin Ammeliorates High Glucose Induced-Cardiac Dysfuntion in Human iPSC-Derived Cardiomyocytes

Figure 5

Effects of High Glucose, Empagliflozin and insulin on the expression of glucose transporters in hiPSC-derived Cardiomyocytes. (A) Schematic outline of the times and durations of high glucose treatment and the application of empagliflozin and insulin. (B,C) Relative expressions of SGLT1 and SGLT2. (D and E) Relative expressions of GLUT1 and GLUT4. *p < 0.05 and **p < 0.01.

Back to article page